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Effectiveness of a 12-week cognitive training (CT) program for community-dwelling patients with
dementia was evaluated on various cognitive functions (attention, memory, executive functions and
reasoning) and psychological well-being (PWB). A single-blind randomized controlled trial was
conducted in adult day care centers in Helsinki, Finland. Participants (N = 147) were older
individuals with mild to moderate dementia living at home and attending day care (mean age 83
years, 72% female, 63% at mild stage of dementia). The intervention group (n = 76) received
systematic CT for 45 minutes twice a week while the control group (n = 71) attended day care as
usual. The cognitive and psychological outcomes were measured at baseline, and followed up at 3
and 9 months. No differences between the two groups in changes of any of the cognitive functions,
or PWB over time were found. We observed a positive trend at 3 months in the change for PWB
favoring the intervention group, but no significant interaction effect was found (p = .079; d = -0.31).
Thus, systematic CT appears to have no effect on neuropsychological outcomes of cognitive
functioning and PWB in older adults who already have dementia.
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INTRODUCTION
The worldwide prevalence and the associated costs of Alzheimer’s disease (AD) and other
neurodegenerative disorders are ever increasing.1 Current pharmacological treatments provide
limited benefits, and efforts have been made to identify effective non-pharmacological approaches
to prevent or slow down the symptoms of neurodegenerative disorders.2 Cognitive dysfunction is a
key feature in AD and other dementia. Numerous activities of daily living and independent behavior
rely upon memory, executive and other essential cognitive functions, which deteriorate
progressively in different types of dementia.3-5 Executive functioning encompasses several
cognitive skills, such as updating working memory representations, paying selective attention,
planning, and inhibitory self-control.6,7 Rehabilitation techniques designed to improve such skills
are likely to support independence and quality of life of persons with dementia.8
Treatment modalities specifically designed to target cognitive impairment include general cognitive
stimulation, practice-oriented cognitive training (CT), and individualized cognitive rehabilitation.9
CT is a feasible, low-cost, and face-valid training method used in various rehabilitation contexts. It
refers to a behavioral intervention strategy the objective of which is to remediate deterioration in
memory, attention, and other cognitive domains using either restorative or compensatory methods.9-
11 When the aim is restorative, CT involves guided practice on various tasks reflecting specific
cognitive functions.9 Training is typically offered using predesigned paper-and-pencil exercises or
computerized programs with various levels of difficulty. Its effects on cognition and functional
abilities have been widely studied and reviewed among healthy older adults,12-15 in minor
neurocognitive disorders,16,17 as well as in major neurocognitive disorders.18-20 The findings on CT
in mild to moderate dementia have been mixed, and recent systematic reviews suggest little or no
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benefit of CT in dementia.19-20 Moreover, the quality of current evidence is predominantly low,
leading to unclear findings.19-20
Some results in functional brain imaging studies have shown positive effects of CT in AD, which
suggest training-related brain plasticity.21-23 For example, working memory training has been
reported to result in several cognitive benefits, as well as changes in relevant functional magnetic
resonance imaging responses in early AD.22 While the results are encouraging, this study has
methodological limitations, such as non-blinded assessors.22 Similarly, a recent Cochrane review
brings up the still low methodological quality of randomized controlled trials (RCTs) on CT in
dementia.20 Furthermore, based on current evidence on the disease progression in AD, it is unclear
how training-induced plastic changes might affect the brain pathology, which begins 10–20 years
before the onset of overt cognitive symptoms.24 However, enhancement of behavioral mechanisms,
such as executive function, might benefit the persons with dementia in daily life.
Generalization of the training effects is another presumption of CT: repeated training is assumed to
lead to improvements beyond the trained cognitive ability.25 According to recent reviews, however,
a typical CT-related finding in patients with AD is a near transfer effect: a post-intervention benefit
on a training-specific cognitive outcome, or global cognitive status.19,20 Furthermore, evidence on
the maintenance of the intervention effects is often lacking.19
The Finnish Cognitive Intervention (FINCOG) study is a well-controlled randomized trial with
adequate power calculations and two post-intervention assessments to explore clinically meaningful
intervention outcomes of cognition, health-related quality of life and psychological well-being
(PWB), and the stability of the potential training effects. A systematic, theoretically sound training
program was used to evaluate the effectiveness of CT in older patients with mild to moderate
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dementia, still living at home. The training program focused on relevant subskills of executive
functioning (i.e. selective attention, working memory, cognitive flexibility and planning), and the
trial outcomes included cognitive tasks reflecting these skills.
The primary results of the FINCOG trial on global cognition and health-related quality of life of
persons with dementia have been reported elsewhere and showed no effect of CT.26 Here we report
all the secondary measures of the trial, which include clinically relevant outcomes of executive
functioning, attention, working memory, episodic memory, reasoning and PWB of the participants.
Our training program was designed to facilitate subskills of executive function, and despite the
negative finding in a global cognitive scale, we were interested to find out whether this kind of
training has the potential to improve, stabilize, or slow down the decline of specific cognitive skills
in older persons with dementia. Prior to our trial, based on the previous RCTs on CT in dementia,
we hypothesized that one or two domains of cognitive functioning should have a positive response
to CT if training is effective in this patient population.19 However, we did not expect any treatment
effect on episodic memory of the participants, who predominantly had a diagnosis of AD.
Additionally, we wanted to find out if CT has a positive impact on the PWB of the older persons
with dementia.
METHODS
The FINCOG study is a single-blind, randomized, controlled two-arm trial (an intervention and a
treatment-as-usual control group) with a 3-month and 9-month follow-up. A 12-week CT program
was run in 14 adult day care centers in Helsinki, Finland, from September 2014 to March 2016. The
study design, the enrollment of the participants, the endpoints of the FINCOG trial, and the
feasibility of the treatment have been reported previously.27
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Ethical approval was obtained from the Helsinki University Central Hospital ethics committee, and
the procedures were planned in accordance with the Declaration of Helsinki. The trial was
registered at the Australian and New Zealand Clinical Trials Registry (identifier:
ACTRN12614000976684). Informed consent was obtained from each participant before any study
procedures began. In cases of reduced judgment capacity (Mini Mental State Examination, MMSE,
score < 20),28 the closest proxy (a spouse or a relative) gave their informed consent.
Participants
A total of 302 patients with an established dementia diagnosis, and who were attending an adult day
care center twice a week in Helsinki, Finland, were invited to take part in the study. Of these, 155
patients (112 women, 43 men) were recruited; they met the inclusion criteria and agreed to
participate. The inclusion criteria were: (1) AD or other dementia at a very mild, mild or moderate
stage (Clinical Dementia Rating scale, CDR, 0.5 to 2);29 (2) aged ≥ 65 years; (3) Finnish-speaking;
(4) able to see, hear, read and write; (5) living at home; and (6) attending an adult day care center at
least twice a week. The following exclusion criteria were applied: any terminal disease; severe loss
of communicative ability; waiting to be institutionalized; and having no available proxy. Those
excluded from the trial did not differ from the participants with respect to age or gender.27
Figure 1 comprises the flow chart of the trial with the available data at each follow-up point. After
the baseline assessment 147 participants were randomized to the intervention group (n = 76) and
control group (n = 71) using computer-generated randomly allocated numbers received by
telephone from a randomization center. To facilitate training in small groups, participants attending
a day care center on the same days were randomized in pairs. However, 18 were randomized
individually because no trial participants attended a center on the same weekdays.
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[INSERT FIGURE 1 HERE]
Interventions
A systematic CT program, based on paper-and-pencil tasks with cognition as a primary target, was
designed for the FINCOG trial. The main objective was to train subskills of executive functioning:
selective attention, working memory, cognitive flexibility and planning. Our program was a
relevant modification of cognitive remediation therapy (CRT), which is a training-based
intervention aimed at improving executive functioning among chronic psychiatric patients.30 When
facilitated by clinicians, CRT is viewed as an evidence-based psychological method in cognitive
rehabilitation.31 We adjusted the program to fit our older patient population by decreasing the
difficulty level of the ready-made CRT tasks, reducing the number of sessions from 40 to 24, and
increasing the font size of the paper-and-pencil tasks.26 Rehabilitation techniques of repeated
practice, errorless learning (in FINCOG: reducing the opportunity to make errors), immediate
feedback, scaffolding (in FINCOG: providing strategies when needed, and gradually increasing task
complexity), and facilitating planning before starting a new task were used in the program.30 Task
examples of FINCOG training are listed in Table 1.
[INSERT TABLE 1 HERE]
The 12-week CT intervention took place in two 45-minute sessions per week during day care visits.
Each session included cognitive exercises from four task categories: visuomotor, perceptual,
conceptual, and interactive tasks (e.g. simple word or card games). Interactive tasks were included
at the end of each session for up to 10 minutes to keep up the participants’ training motivation.
Training was tailored according to the participants’ cognitive abilities, and was accordingly
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implemented either in small groups of two to four persons or individually when needed (18 cases,
due to difficulties in concentration, or lack of a training pair). The difficulty level was tailored
during the sessions, but it was not automatic (as in computerized training). Trained psychology
students administered CT under the guidance and supervision of an experienced neuropsychologist.
The intervention was feasible in terms of a mean attendance of 22 (92%) sessions, and favorable
feedback from the participants and nurses in the adult care centers.27 In two of the 14 centers the
nurses started their own small-scale cognition-focused activity for their attendees that included 22
FINCOG participants, nine in the intervention group and 13 in the control group. Due to occasional
implementation, and quite well balanced distribution of this activity, the participants were kept in
their randomized research arms. If there was any self-administered home-based training during the
trial, it was not collected.
Both the intervention and control groups received routine treatment at a day care center twice a
week for six hours each day. Routine treatment included nonspecific psychosocial (group
discussions, musical activities, lunch and coffee), physical (light exercise, walking outdoors), and
nonspecific cognitive activities (e.g., orientation to time, simple games, reminiscence of major
public events) in groups of 12–16.
Measures
The severity of dementia and the cognitive status of the participants were assessed at baseline using
CDR and MMSE, respectively. The Alzheimer’s Disease Assessment Scale - Cognitive subscale
(ADAS-Cog)32 was used as a measure of global cognition, as well as in assessing the primary
outcome of the trial.26 A set of standard neuropsychological tests for executive and cognitive
functioning were used as secondary trial outcomes to evaluate the effects of CT on relevant
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cognitive domains. Additionally, the PWB of the participants was assessed by means of a short
questionnaire.
· Executive functioning: The total score of the Frontal Assessment Battery (FAB) was used as
a global measure of executive functioning.33 FAB is a short, bedside neuropsychological
battery, yielding a maximum score of 18, for assessing patients with neurocognitive
disorders to indicate executive dysfunction.33 The six tasks explore conceptualization and
abstract reasoning, lexical fluency, motor programming, sensitivity to interference, and
executive control of action.33 The Clock Drawing test (with a range of 0–6 points) of the
Consortium to Establish a Registry for Alzheimer's Disease (CERAD) was used as a
measure of planning ability, and verbal fluency as an indicator of mental flexibility and
cognitive productivity.34 Two separate word generation tasks were summarized for a verbal
fluency score: lexical (letter S from FAB) and semantic (animal) fluency, both within one
minute of time.
· Attention and processing speed: Time (in seconds) in Part A of the Trail Making Test
(TMT) was used as a measure of selective attention and speed of mental processing.35
· Working memory: A verbal Digit Span task from the Finnish Wechsler Memory Scale,
Third Edition (WMS-III) was used as a measure of working memory capacity involving
both the forward and the backward conditions.36 A total score from the two conditions was
calculated, yielding a maximum of 32 points.
· Episodic memory: The 12-item Word Recognition task of the ADAS-Cog was used as a
measure of episodic memory.32 The episodic memory score equals the percentage of correct
responses in the first round of the task, in which the 12 studied words are mixed with 12
new words.
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· Reasoning: Verbal concept formation and reasoning were assessed on the Similarities
subtest, and visuospatial reasoning was measured by means of Block Design, both from the
Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV).37
· Psychological well-being: The PWB scale includes six questions about life satisfaction,
feeling needed, having plans for the future, having a zest for life, feeling depressed, and
suffering from loneliness.38 These simple questions have been used among older persons
with dementia, and have been found easy to understand and to answer.38,39 The PWB index
score varies between 0 (poor well-being) and 1 (excellent well-being) and can be classified
as good (PWB ≥ .80), moderate (.80 > PWB ≥ .40) or poor (PWB < .40).39 In our trial, the
PWB responses came from a structured interview with the participant.
Additional cognitive measures for executive functioning (Stroop Test), and attention and processing
speed (Coding from the WAIS-IV) were excluded from the neuropsychological test battery. Both
measures had missing data at baseline in more than 15% of the participants due to excessive
complexity.
The participants were assessed three times during the trial: at baseline, and at 3 and 9 months. An
experienced neuropsychologist who was blind to the group assignment carried out all of the
cognitive assessments, except MMSE. Two similarly blinded study nurses assessed the other
outcome measures, including MMSE.
Statistical Analyses
The power calculation of the FINCOG trial was based on the primary cognitive outcome, ADAS-
Cog.27 A four-point change in the ADAS-Cog was considered a clinically meaningful difference
between the intervention and the control group.27,40 Therefore, a sample size of 64 per group was
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calculated to ensure 80% power to detect this difference with a standard deviation of 8 and a type I
error rate of 5%. An estimated dropout rate was 20% during the follow-up. An intention-to-treat
analysis was applied: all participants assessed at baseline and in at least one of the follow-ups were
included in the analyses.
The data are presented as means with standard deviations for the continuous variables, and as
numbers and percentages for the categorical variables. Statistical comparison between the groups at
baseline was determined by means of a t-test, a permutation test or a Chi-square test, as appropriate.
The mean changes between the baseline and 3-month measures were assessed using bootstrap type
analysis of covariance (ANCOVA), with age, gender, educational level and baseline measure as
covariates; 95% confidence intervals (CI) were obtained by means of bias-corrected bootstrapping
(5,000 replications). The standardized response mean (SRM; mean change/SD of change) of each
cognitive measure between the baseline and 3-month assessments was used to compare the
responsiveness of different cognitive domains to the intervention. Effect size (d) was calculated by
using the method of Cohen. CIs for the SRM and effect sizes were obtained by means of bias-
corrected bootstrapping (5,000 replications). The normality of the variables was evaluated using the
Shapiro-Wilk W test. Stata Statistical Software (Release 15.0, StataCorp, College Station, Texas)
was used for the statistical analyses.
RESULTS
Baseline comparisons
There were no differences between the intervention and control group in the participants’ baseline
characteristics: demographics (age, sex, and education), self- or proxy-rated functional
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characteristics (living alone, daily activities, self-rated psychological well-being), and clinical
characteristics (dementia diagnoses, CDR, MMSE, comorbidities, and number of medications).27
Table 1 gives the details. The mean age of the 147 participants was 83.1 years, 71% were female,
and the mean MMSE score was 20. According to the CDR, 37% of the randomized participants had
moderate dementia (CDR 2), 53% were at a mild stage (CDR 1), and only 10% were at a very mild
stage (CDR 0.5). The primary clinical diagnosis of dementia was AD in 122 participants (NINCS-
ADRDA criteria).41 The mean PWB score of 0.75 indicated moderate psychological well-being at
baseline.
In addition, Table 2 shows the cognitive and psychological outcome measures at baseline.
Participants in the intervention and the control groups differed significantly on one cognitive
measure, the FAB, with those in the intervention group scoring slightly higher than those in the
control group. However, both groups had a mean score of less than 12, which indicates executive
dysfunction.42
[INSERT TABLE 2 HERE]
Effects of the intervention on cognitive functioning
As Table 3 shows, there were no differences between the two groups in the change for any
cognitive measure over three months (adjusted for age, sex, educational level, and respective
baseline measure). Additional analyses without the 13 control participants who participated in
occasional “extra training” did not change the finding in any cognitive measure (data not shown).
Figure 2 shows the SRMs of the different cognitive measures in both groups between pre- and post-
treatment assessments. The responses of the cognitive outcomes did not differ from each other.
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[INSERT TABLE 3 HERE]
[INSERT FIGURE 2 HERE]
We further explored whether patients with mild dementia (CDR 0.5-1) would benefit from CT. In
subgroup analyses with 49 participants in the intervention group and 43 participants in the control
group the responses of seven cognitive outcomes (FAB, Clock Test, Fluency, Digit Span,
Recognition, Similarities and Block Design) did not differ between the groups at 3 months. The
mean time for the Trail Making test, Part A (i.e. TMT) increased in the intervention group by 7
seconds (95% CI = -4 to 19) and decreased in the control group by 8 seconds (95% CI = -19 to 2) at
3 months (p = .026, adjusted for age, sex, educational level and baseline measure). However, the
mean time and standard deviation for both the intervention group (M = 137, SD 63), and the control
group (M = 143, SD = 60) already show severe difficulties in task performance of TMT at baseline,
resulting in large variance across participants, which may explain this unexpected finding.
Effects of the intervention on psychological well-being
There were no differences between the two groups in the extent of change in PWB over time. A
positive trend at 3 months was observed for the intervention group: the PWB score declined from
the baseline by -0.01 (95% CI = -0.04 to 0.02) in the intervention group, whereas the respective
change in the control group was -0.06 (95% CI = -0.10 to -0.02), but no significant interaction
effect was found (p = .079, d = -0.31). The PWB score returned close to baseline score in both
groups at 9 months.
[INSERT FIGURE 3 HERE]
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DISCUSSION
The FINCOG trial examined the effectiveness of a systematic 12-week CT program on secondary
trial outcomes of cognition and PWB in community-dwelling older adults with mild to moderate
dementia. Training was specifically designed to remediate subskills of executive functioning:
selective attention, working memory, cognitive flexibility, and planning. No beneficial effects were
found in attention, working memory, episodic memory, executive functions, reasoning, or PWB
after the training. We expected the difference in cognitive functioning to be highest right after the
intervention. When no differences were found between the intervention and control group at 3
months, we did not test the differences at 9 months. A weak trend at the post-intervention
assessment suggested a change in PWB favoring the intervention group, but the difference between
the two groups was not statistically significant. Additionally, PWB returned close to baseline in
both groups at 9 months. Similarly, our previously reported primary FINCOG outcomes of global
cognition and health-related quality of life showed no beneficial effect of CT.26
The pragmatic nature of our study is one of its strengths but may partially explain the negative
findings. We kept the exclusion criteria to a minimum, allowed various dementia diagnoses, both
mild and moderate stages of dementia, as well as very old persons with comorbid conditions. The
FINCOG participants were a bit older and had a higher number of comorbidities and disabilities
than those in many previous dementia studies.19 At the same time, our trial included individuals in
somewhat more advanced stages of the disease than in previous trials, where the participants were
typically at a mild stage of dementia.19 Positive effects of CT might be easier to achieve in earlier
stages of dementia, or even before the actual onset of dementia as shown in some previous
trials.17,22,43
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Both the control and intervention group attended day care activities during the trial, i.e. received
regular cognitive activation in peer groups, which has shown efficacy in terms of cognitive status
and some aspects of well-being in dementia, and may have attenuated the effects of FINCOG
training.44 Adult day care activity did include orientation to time, voluntary and nonspecific games,
reminiscence of major public events and so forth, but there were no structured therapy sessions.
FINCOG training was based on systematic and supervised paper-and-pencil exercises with
increasing difficulty, whereas a genuinely adaptive computerized program might have had larger
training effects.43,46 Training was performed in small groups. A recent study comparing group-
based CT with individual-based training suggests that the latter might be more effective.45
However, our CT program was conducted in groups of two to four participants, thus ensuring
sufficient support for the participants to understand the task instructions.
Positive effects of CT on executive functions of patients with dementia have occasionally been
reported in previous RCTs. One study on computerized structured CT (90 minutes a week in three
sessions over 12 weeks) showed improvement in cognitive outcomes, including tests of executive
function and working memory.43 A total of 80 participants in this study were early-stage AD
patients with no common comorbidities of old age. Training was administered individually together
with a neuropsychologist, whereas in our trial it took place in small groups. Another highly
intensive program with five repeated cycles of CT (one cycle: 20 sessions in four weeks) involving
a small group of AD patients resulted in improved performance on several cognitive outcomes after
one year of training.47 Moreover, a few small-scale RCTs have reported CT benefits with regard to
working memory,22,48 decision making,49 and verbal conceptualization,50 but these findings need to
be confirmed.
16
Psychological well-being was evaluated as moderate before the FINCOG intervention, but contrary
to our predictions, no change for the better was observed at post-intervention. There was a weak
trend following the intervention indicating that stability in PWB favored the intervention group, but
the difference between the two groups was not statistically or clinically significant. To our
knowledge, only three previous small-scale RCTs have reported a benefit of CT on mood.51-53 A
positive impact was observed after a short individual memory program (six sessions) focusing on
autobiographical memories, which may have evoked positive thoughts and improved moods among
the participants.51 Additionally, given priority to a therapist-led intervention over a computer-
assisted condition,52 as well as psychological support over cognitive activities,53 has resulted in
beneficial effects on mood.
Despite the negative findings, the present study has several strengths. The FINCOG study
comprises a randomized, single-blind, two-arm controlled trial, with separate research personnel
conducting assessments and interventions. With 147 participants randomized in the two arms, the
sample size was larger than in most previous CT trials in dementia.19 We conducted a detailed
neuropsychological assessment and found no substantive differences between the groups in terms of
demographic characteristics, cognitive or psychological status before the intervention. A small
difference in FAB favored the intervention group at baseline; however, the baseline values were
used as covariates in the analyses. Cognitive intervention was theoretically justified, carefully
planned and executed to meet the cognitive abilities of the target population. The training was
regular, quite intensive and well accepted by the participants; adherence was good in the
intervention arm.27
The current results are consistent with those reported in a large multicenter trial in France
(ETNA3), involving three different cognition-based interventions and a control condition, and
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including a total of 653 Alzheimer’s patients: no effects of CT on cognition or depressive symptoms
compared to a control group were found.45 As in our trial, the ETNA3 training took place in small
groups and focused on various cognitive functions. Furthermore, active training took place once a
week for 90 minutes over period of three months.45 Thus, our results, with more frequent training,
support these findings.
Overall, the results of the FINCOG trial add to the evidence of the ineffectiveness of CT in
dementia, which has recently also been noticed in clinical guidelines for dementia care.54 The trial
was based on rigorous RCT methodology, was conducted in a real-world setting, and involved a
large group of older adults with mild to moderate dementia. Systematic CT delivered in 24 sessions
had no effect on domain-specific cognitive functioning or PWB of the community-dwelling
patients. Therefore, the neuropsychological findings of the FINCOG trial do not support the
effectiveness of CT among patients with established dementia.
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FINCOG, Finnish Cognitive Intervention
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(n = 71) P-value
Age, mean (SD) 82.6 (5.5) 83.6 (5.4) 0.24
Female, % 65.8 78.9 0.08



























Charlson index, mean (SD) 2.7 (1.6) 2.8 (1.9) 0.96
Number of medications, mean (SD) 8.2 (3.2) 7.8 (3.0) 0.34
On AD medication, % 78.9 87.4 0.54
On anticholinergics, % 43.4 52.1 0.29
Living alone, % 71.1 70.4 0.93











Executive functioning, mean (SD)
FAB, total score
Clock Test (CERAD)











TMT, Part A, time (s) 145 (63) 155 (72) 0.37
Working memory, mean (SD)
Digit Span, total score (WMS III) 13.1 (3.2) 12.4 (3.0) 0.14
Episodic memory, mean (SD)










PWB, mean (SD) 0.75 (0.16) 0.76 (0.18) 0.32
AD, Alzheimer’s Disease; CDR, Clinical Dementia Rating; CERAD, the Consortium to Establish a
Registry for Alzheimer's Disease; FAB, Frontal Assessment Battery; FINCOG, Finnish Cognitive
Intervention; MMSE, Mini-Mental State Examination; PWB, Psychological Well-Being Scale; s,
Seconds; SD, standard deviation; TMT, Trail Making Test; WAIS-IV, Wechsler Adult Intelligence
Scale-Fourth Edition; WMS III, Wechsler Memory Scale-Third Edition
* p < 0.05
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Table 3. Comparisons of mean changes in cognitive measures from baseline to three months in the




Mean Change (95% CI)
Control Group
Mean Change (95% CI)
P-
value Effect Size (95% CI)
FAB -0.1 (-0.6 to 0.4) 0.0 (-0.5 to 0.5) 0.96 0.07 (-0.26 to 0.39)
Clock Test 0.12 (-0.23 to 0.47) 0.06 (-0.30 to 0.41) 0.47 -0.04 (-0.37 to 0.29)
Fluency -0.5 (-1.5 to 0.5) -0.2 (-1.4 to 1.1) 0.98 0.06 (-0.27 to 0.39)
TMT 7 (-4 to 17) -6 (-15 to 4) 0.09 -0.29 (-0.64 to 0.05)
Digit Span 0.1 (-0.4 to 0.7) -0.3 (-0.8 to 0.2) 0.09 -0.20 (-0.55 to 0.15)
Recognition -1.9 (-4.3 to 0.5) -2.2 (-5.1 to 0.7) 0.41 -0.03 (-0.36 to 0.30)
Similarities 0.6 (-0.3 to 1.5) 0.4 (-0.7 to 1.5) 0.30 -0.05 (-0.39 to 0.28)
Block Design -0.2 (-1.7 to 1.3) -0.8 (-2.2 to 0.7) 0.40 -0.10 (-0.44 to 0.25)
CI, confidence interval; FAB, Frontal Assessment Battery; TMT, Trail-Making Test.
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FIGURES
Figure 1. Flowchart of the FINCOG trial (adapted from Kallio et al., 201826)
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Figure 2. Standardized response means (SRMs) from baseline to 3-month assessment in cognitive
outcomes in the intervention and control groups. For the purpose of comparing the changes, the
standardized response mean (mean change/SD of change) of each measure was applied.
Standardized Response Mean













Figure 3. Mean changes in the intervention and control groups in psychological well-being (PWB)
relative to baseline at 3-month and 9-month assessment points (adjusted for age and sex). The range
of PWB scores is 0–1, and higher scores indicate greater well-being.
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